{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-002241","form_type":"8-K","ticker":"BRKR","cik":"0001109354","company_name":"BRUKER CORP","filed_at":"2023-02-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:43.893094+00:00","generated_at":"2026-06-19T19:14:59.057412+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Bruker Q4 non-GAAP EPS $0.74 (+25% YoY); FY23 organic growth guidance 8-10%","bullets":["Q4 revenues $708.4M (+3.6% reported, +8.9% organic); GAAP EPS $0.66 vs $0.50.","FY22 revenues $2.531B (+4.7% reported, +10.2% organic); non-GAAP EPS $2.34 (+11.4%).","FY23 guidance: revenue $2.81-2.86B (8-10% organic); non-GAAP EPS $2.52-2.57 (8-10% growth).","BSI organic growth 9.5% (FY); BEST organic growth 17.4%; non-GAAP op margin expanded to 20.0%.","Management cites double-digit organic bookings growth and accelerated investments in proteomics."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-002241","json":"https://secwatch.observer/filing/0000950170-23-002241.json","markdown":"https://secwatch.observer/filing/0000950170-23-002241.md","text":"https://secwatch.observer/filing/0000950170-23-002241.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1109354/000095017023002241/0000950170-23-002241-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1109354/000095017023002241/brkr-20230209.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T19:14:59.057412+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0dae7f6801056c865584e2c950380eaab325633d","claim":"BRUKER CORP reported the three months ended December 31, 2022 results: revenue $708.4 million, EPS $0.66.","evidence_excerpt":"9 – Financial Statements and Exhibits --- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 Bruker Reports Fourth Quarter and Fiscal Year 2022 Financial Results • Q4 2022 revenues $708.4 million, up 3.6% year-over-year (yoy); organic revenue growth of 8.9% • Q4 2022 GAAP EPS $0.66; non-GAAP EPS $0.74, up 25.4% yoy • FY 2022 revenues $2.531 billion, up 4.7% yoy; organic","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1109354/000095017023002241/0000950170-23-002241-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three months ended December 31, 2022"},{"label":"Revenue","value":"$708.4 million"},{"label":"EPS","value":"$0.66"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"5961c9cf366f62ee46f590cd3e3af15fc8e4eb1d","claim":"BRUKER CORP reported FY 2023 results: revenue $2.81 to $2.86 billion, EPS $2.52 to $2.57. Guidance initiated.","evidence_excerpt":"For FY 2023, Bruker expects revenue of $2.81 to $2.86 billion, or 11% to 13% year-over-year reported revenue growth","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1109354/000095017023002241/0000950170-23-002241-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"FY 2023"},{"label":"Revenue","value":"$2.81 to $2.86 billion"},{"label":"EPS","value":"$2.52 to $2.57"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"b5474937fcba796c00953b617f7118c392d6f61f","claim":"BRUKER CORP reported the year ended December 31, 2022 results: revenue $2.531 billion, EPS $1.99.","evidence_excerpt":"• Q4 2022 revenues $708.4 million, up 3.6% year-over-year (yoy); organic revenue growth of 8.9% • Q4 2022 GAAP EPS $0.66; non-GAAP EPS $0.74, up 25.4% yoy • FY 2022 revenues $2.531 billion, up 4.7% yoy; organic revenue growth of 10.2% • FY 2022 GAAP EPS $1.99; non-GAAP EPS $2.34, up 11.4% yoy • Bruker expects FY 2023 organic revenue growth of 8% to 10% yoy","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1109354/000095017023002241/0000950170-23-002241-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the year ended December 31, 2022"},{"label":"Revenue","value":"$2.531 billion"},{"label":"EPS","value":"$1.99"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}